ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,471, issued on Oct. 27, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.).
"Engineered Streptomyces albus strains" was invented by Hendrik Luesch (Gainesville, Fla.) and Dimitrios Kallifidas (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "In some aspects, the disclosure relates to production of bacterial secondary metabolites. In some embodiments, the disclosure relates to a genetically engineered Streptomyces J1074 bacterium, wherein the bacterium comprises a nucleic acid having a modification to at least one global regulator gene."
The patent was filed on April 5, 2019, under Application No. 17/04...